These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16384550)

  • 1. Both PA63 and PA83 are endocytosed within an anthrax protective antigen mixed heptamer: a putative mechanism to overcome a furin deficiency.
    Chekanov AV; Remacle AG; Golubkov VS; Akatov VS; Sikora S; Savinov AY; Fugere M; Day R; Rozanov DV; Strongin AY
    Arch Biochem Biophys; 2006 Feb; 446(1):52-9. PubMed ID: 16384550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of the Bacillus anthracis 20 kDa protective antigen component.
    Hammamieh R; Ribot WJ; Abshire TG; Jett M; Ezzell J
    BMC Infect Dis; 2008 Sep; 8():124. PubMed ID: 18808698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular model of anthrax toxin translocation into target-cells].
    Noskov AN
    Bioorg Khim; 2014; 40(4):399-404. PubMed ID: 25898749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accurate and selective quantification of anthrax protective antigen in plasma by immunocapture and isotope dilution mass spectrometry.
    Solano MI; Woolfitt AR; Boyer AE; Lins RC; Isbell K; Gallegos-Candela M; Moura H; Pierce CL; Barr JR
    Analyst; 2019 Mar; 144(7):2264-2274. PubMed ID: 30810119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligomerization of anthrax toxin protective antigen and binding of lethal factor during endocytic uptake into mammalian cells.
    Singh Y; Klimpel KR; Goel S; Swain PK; Leppla SH
    Infect Immun; 1999 Apr; 67(4):1853-9. PubMed ID: 10085027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anthrax protective antigen (PA63) bound conformation of a peptide inhibitor of the binding of lethal factor to PA63: as determined by trNOESY NMR and molecular modeling.
    Hicks RP; Bhattacharjee AK; Koser BW; Traficante DD
    J Med Chem; 2004 Oct; 47(22):5347-55. PubMed ID: 15481973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution Structures of
    Michelman-Ribeiro A; Rubinson KA; Silin V; Kasianowicz JJ
    Toxins (Basel); 2021 Dec; 13(12):. PubMed ID: 34941724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthrax protective antigen cleavage and clearance from the blood of mice and rats.
    Moayeri M; Wiggins JF; Leppla SH
    Infect Immun; 2007 Nov; 75(11):5175-84. PubMed ID: 17724066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of a complex between anthrax toxin and its host cell receptor.
    Santelli E; Bankston LA; Leppla SH; Liddington RC
    Nature; 2004 Aug; 430(7002):905-8. PubMed ID: 15243628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthrax toxin.
    Bhatnagar R; Batra S
    Crit Rev Microbiol; 2001; 27(3):167-200. PubMed ID: 11596878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthrax toxin.
    Collier RJ; Young JA
    Annu Rev Cell Dev Biol; 2003; 19():45-70. PubMed ID: 14570563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-association of the transmembrane domain of an anthrax toxin receptor.
    Go MY; Kim S; Partridge AW; Melnyk RA; Rath A; Deber CM; Mogridge J
    J Mol Biol; 2006 Jun; 360(1):145-56. PubMed ID: 16756998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro processing of anthrax toxin protective antigen by recombinant PC1 (SPC3) and bovine intermediate lobe secretory vesicle membranes.
    Friedman TC; Gordon VM; Leppla SH; Klimpel KR; Birch NP; Loh YP
    Arch Biochem Biophys; 1995 Jan; 316(1):5-13. PubMed ID: 7840657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane type-1 matrix metalloproteinase (MT1-MMP) protects malignant cells from tumoricidal activity of re-engineered anthrax lethal toxin.
    Rozanov DV; Golubkov VS; Strongin AY
    Int J Biochem Cell Biol; 2005 Jan; 37(1):142-54. PubMed ID: 15381157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton-coupled protein transport through the anthrax toxin channel.
    Finkelstein A
    Philos Trans R Soc Lond B Biol Sci; 2009 Jan; 364(1514):209-15. PubMed ID: 18957378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lethal factor of anthrax toxin binds monomeric form of protective antigen.
    Chvyrkova I; Zhang XC; Terzyan S
    Biochem Biophys Res Commun; 2007 Aug; 360(3):690-5. PubMed ID: 17617379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New aspects of the infection mechanisms of Bacillus anthracis.
    Zakowska D; Bartoszcze M; Niemcewicz M; Bielawska-Drózd A; Kocik J
    Ann Agric Environ Med; 2012; 19(4):613-8. PubMed ID: 23311776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen.
    Mogridge J; Cunningham K; Lacy DB; Mourez M; Collier RJ
    Proc Natl Acad Sci U S A; 2002 May; 99(10):7045-8. PubMed ID: 11997437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The channel formed in planar lipid bilayers by the protective antigen component of anthrax toxin.
    Finkelstein A
    Toxicology; 1994 Feb; 87(1-3):29-41. PubMed ID: 7512762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A femtomol range FRET biosensor reports exceedingly low levels of cell surface furin: implications for the processing of anthrax protective antigen.
    Gawlik K; Remacle AG; Shiryaev SA; Golubkov VS; Ouyang M; Wang Y; Strongin AY
    PLoS One; 2010 Jun; 5(6):e11305. PubMed ID: 20585585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.